GLS Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (10 apr 2023 @ 22:00):

Gelesis Holdings Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases...

Stats
Dagens volum	185 167
Gjennomsnittsvolum	570 667
Markedsverdi	11.63M
EPS	$0 ( 2024-03-26 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.122
ATR14	$0.0180 (148.76%)

Insider Trading

Date	Person	Action	Amount	type
2023-09-20	Puretech Health Plc	Buy	0	Convertible Note
2023-06-12	Puretech Health Plc	Buy	0	Convertible Note
2023-05-26	Puretech Health Plc	Buy	43 133 803	Warrants
2023-05-26	Puretech Health Plc	Buy	0	Convertible Note
2023-05-01	Puretech Health Plc	Buy	192 307 692	Warrants

INSIDER POWER
99.96
Last 86 transactions
Buy: 269 373 579 \| Sell: 26 728 050

Volum Korrelasjon

Lang: -0.10 (neutral)

Kort: -0.99 (very strong negative)

Signal:(31.483) Neutral

Gelesis Holdings, Inc. Korrelasjon

10 Mest positive korrelasjoner
TBI	0.855
VFC	0.849
NBHC	0.848
AFG	0.839
AUD	0.836
HP	0.832
COP	0.827
ETRN	0.825
DVN	0.822
BOC	0.821

10 Mest negative korrelasjoner
DSE	-0.846
IOT	-0.83
BBL	-0.812
IDT	-0.811
MIC	-0.811
FPAC-UN	-0.805
YEXT	-0.805

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Gelesis Holdings, Inc. Korrelasjon - Valuta/Råvare

0.18
( neutral )

-0.64
( weak negative )

0.00
( neutral )

-0.18
( neutral )

0.79
( moderate )

-0.21
( neutral )

Gelesis Holdings, Inc. Økonomi

Annual	2022
Omsetning:	$25.77M
Bruttogevinst:	$-1.79M (-6.95 %)
EPS:	$-0.790

FY	2022
Omsetning:	$25.77M
Bruttogevinst:	$-1.79M (-6.95 %)
EPS:	$-0.790

FY	2021
Omsetning:	$11.19M
Bruttogevinst:	$1.20M (10.75 %)
EPS:	$-0.0423

Financial Reports:

No articles found.

Gelesis Holdings, Inc.

Gelesis Holdings Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. The company also provides PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, it offers a product for obesity and overweight and a pipeline with potential therapies for non-alcoholic fatty liver disease/non-alcoholic steatohepatitis, type 2 diabetes, and GS500 for Functional Constipation. Gelesis Holdings Inc. was incorporated in 2006 and is headquartered in Boston, Massachusetts.